Nanoformulation mediated silencing of P-gp efflux protein for the efficient oral delivery of anti-leishmanial drugs-Reference-Cited by-同舟云学术

Nanoformulation mediated silencing of P-gp efflux protein for the efficient oral delivery of anti-leishmanial drugs

Published:2022-12 Issue: Volume:78 Page:103959
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Parvez Shabi^ORCID,Karole Archana,Dinakar Yirivinti Hayagreeva,Mudavath Shyam Lal^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference59 articles.

1. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability;Amidon;Pharm. Res. An Off. J. Am. Assoc. Pharm. Sci.,1995

2. Drug dissolution: significance of physicochemical properties and physiological conditions;Jambhekar;Drug Discov. Today,2013

3. Exploring the role of different drug transport routes in permeability screening;Matsson;J. Med. Chem.,2005

4. Advanced nanoscale carrier-based approaches to overcome biopharmaceutical issues associated with anticancer drug ‘Etoposide;Choudhury;Mater. Sci. Eng. C.,2020

5. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance;Zhao;Mater. Sci. Eng. C,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and evaluation of WK-X-34 derivatives as P-glycoprotein (P-gp/ABCB1) inhibitors for reversing multidrug resistance;RSC Medicinal Chemistry;2024

2. Recent Advances of Multifunctional PLGA Nanocarriers in the Management of Triple-Negative Breast Cancer;AAPS PharmSciTech;2023-12-14